These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1626554)

  • 21. [Italian Registry of Dialysis and Transplantation: 1996-2001 experience].
    Conte F; Cappelli G; Casino F; Postorino M; Quintaliani G; Salomone M; Di Napoli A; Limido A; Mancini E; Nordio M; Pinna A; Santoro D; Alloatti S; Bellinghieri G; Bonadonna A; Bonomini M; Colasanti G; Di Giulio S; Di Iorio B; Di Lallo D; Gaffi G; Gesualdo L; Locatelli F; Piccoli G; Quarello F; Riegler P; Salvadori M; Santoro A; Sparano G; Vasile A;
    G Ital Nefrol; 2004; 21(6):561-7. PubMed ID: 15593024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Course of chronic renal failure epidemiology and prediction of maintenance dialysis needs in France].
    Jungers P; Robino C; Choukroun G; Touam M; Fakhouri F; Grünfeld JP
    Nephrologie; 2001; 22(3):91-7. PubMed ID: 11436669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic kidney failure with dialysis and transplantation. Development, need and organization in Norway].
    Fauchald P; Joachim Berg K; Brodwall EK; Talseth T; Flatmark A; Leivestad T; Halvorsen S
    Tidsskr Nor Laegeforen; 1990 Jan; 110(3):332-4. PubMed ID: 2309173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Worldwide demographics and future trends of the management of renal failure in the elderly.
    Mignon F; Michel C; Mentre F; Viron B
    Kidney Int Suppl; 1993 Jun; 41():S18-26. PubMed ID: 8320916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
    Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of mortality risk by choice of CAPD versus hemodialysis among elderly patients.
    Lunde NM; Port FK; Wolfe RA; Guire KE
    Adv Perit Dial; 1991; 7():68-72. PubMed ID: 1680460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.
    Yang WC; Hwang SJ;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3977-82. PubMed ID: 18628366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. End-stage renal disease and its treatment in Latin America in the twenty-first century.
    Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
    Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptance for chronic dialysis treatment: insufficient and unequal.
    Sesso R; Fernandes PF; Anção M; Drummond M; Draibe S; Sigulem D; Ajzen H
    Nephrol Dial Transplant; 1996 Jun; 11(6):982-6. PubMed ID: 8671956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
    Shih YC; Guo A; Just PM; Mujais S
    Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of transplantation on the Medicare end-stage renal disease program.
    Eggers PW
    N Engl J Med; 1988 Jan; 318(4):223-9. PubMed ID: 3275896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of dialysis prescriptions in the US, 1986-1987.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):39-47. PubMed ID: 1442774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes --- United States and Puerto Rico, 1996-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(42):1361-6. PubMed ID: 21030940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in hip fracture rates in US hemodialysis patients, 1993-2010.
    Arneson TJ; Li S; Liu J; Kilpatrick RD; Newsome BB; St Peter WL
    Am J Kidney Dis; 2013 Oct; 62(4):747-54. PubMed ID: 23631997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stopping long-term dialysis. An empirical study of withdrawal of life-supporting treatment.
    Neu S; Kjellstrand CM
    N Engl J Med; 1986 Jan; 314(1):14-20. PubMed ID: 3079619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvements in data quality in the USRDS database: determining treatment modalities.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):89-94. PubMed ID: 1442780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.
    Butler AM; Olshan AF; Kshirsagar AV; Edwards JK; Nielsen ME; Wheeler SB; Brookhart MA
    Am J Kidney Dis; 2015 May; 65(5):763-72. PubMed ID: 25662835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.